“SpePharm has established a fruitful collaboration with Vigilex over the last 18 months for the company's pharmacovigilance activities both in the Netherlands and at corporate level. Vigilex staff high professional and communication skills have permitted a smooth and efficient take-over of extended pharmacovigilance activities on a multinational basis, while maintaining transparent and efficient collaboration and communication with our US, Japanese and local partners in some EU territories. Vigilex expertise is highly supported by their in-depth knowledge of pharmacovigilance regulatory requirements”.
Caroline Dumas, MD Vice President, Medical Affairs